These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14889080)

  • 1. Metabolic effects of compound S (11-desoxy-17-hydroxycorticosterone) in man.
    FAJANS SS; LOUIS LH; CONN JW
    J Lab Clin Med; 1951 Dec; 38(6):911-5. PubMed ID: 14889080
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of adrenal cortical extract, 11-desoxy-17-hydroxycorticosterone acetate (compound S) and 11-dehydrocorticosterone acetate (compound A) on the cardiovascular-renal action of desoxycorticosterone acetate.
    FRIEDMAN SM; FRIEDMAN CL
    Endocrinology; 1951 Sep; 49(3):318-24. PubMed ID: 14887645
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the comparative activities of desoxycorticosterone and Reichstein's Compound S.
    HALL CE; HALL O; McCLESHEY O
    Acta Endocrinol (Copenh); 1952 Feb; 9(2):199-210. PubMed ID: 14932706
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral antagonism between hydrocortisone and compound S.
    RINDANI TH
    Proc Soc Exp Biol Med; 1954 Nov; 87(2):345-6. PubMed ID: 13237239
    [No Abstract]   [Full Text] [Related]  

  • 5. C(14)-substituted corticosteroids; some D ring transformations in the compound S series.
    BLOOM BM; AGNELLO EJ; LAUBACH GD
    Experientia; 1956 Jan; 12(1):27-30. PubMed ID: 13305572
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of Reichstein's substance S in the treatment of cancer.
    RIVER L; SILVERSTEIN J; DOLEHIDE E
    Ill Med J; 1953 Aug; 104(2):126-7. PubMed ID: 13069068
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of Reichstein's substance S on 17-ketosteroid excretion; preliminary report].
    BIRKE G; PLANTIN LO
    Nord Med; 1953 Jun; 49(25):867-8. PubMed ID: 13087711
    [No Abstract]   [Full Text] [Related]  

  • 8. On the metabolism of Reichstein's substance S.
    BIRKE G; PLANTIN LO
    Science; 1953 Dec; 118(3077):751. PubMed ID: 13122010
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of 11-deoxycortisol in vitro.
    FORCHIELLI E; ROSENKRANTZ H; DORFMAN RI
    J Biol Chem; 1955 Aug; 215(2):713-22. PubMed ID: 13242571
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of 17-alpha-hydroxy-11-desoxycorticosterone on estrogen-stimulated chick oviduct growth.
    TULLNER WW; HERTZ R
    Endocrinology; 1956 Feb; 58(2):282-3. PubMed ID: 13285476
    [No Abstract]   [Full Text] [Related]  

  • 11. The probability that compound F (17-hydroxycorticosterone) is the hormone produced by the normal human adrenal cortex.
    CONN JW; LOUIS LH; FAJANS SS
    Science; 1951 Jun; 113(2947):713-4. PubMed ID: 14854855
    [No Abstract]   [Full Text] [Related]  

  • 12. The biosynthesis of 17-hydroxycorticosterone from 11-desoxy-17-hydroxy-corticosterone.
    McGINTY DA; SMITH GN; WILSON ML; WORREL CS
    Science; 1950 Oct; 112(2913):506. PubMed ID: 14787451
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of epi-F, a stereoisomer of compound F, on the glycogenic property of compound F (17-hydroxycorticosterone).
    SEGALOFF A; HORWITT BN
    Science; 1953 Aug; 118(3060):220-1. PubMed ID: 13089654
    [No Abstract]   [Full Text] [Related]  

  • 14. Peripheral blood concentrations of steroids in man after oral administration of 17-hydroxycorticosterone.
    RICHARDS JB; SWEAT ML
    Proc Soc Exp Biol Med; 1953 Oct; 84(1):125-7. PubMed ID: 13120957
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma clearance and glucuronide conjugation of 11-desoxycortisol (substance S) in man.
    GOLD EM
    Proc Soc Exp Biol Med; 1960 Apr; 103():829-32. PubMed ID: 13850553
    [No Abstract]   [Full Text] [Related]  

  • 16. Response corticotropin of normal and hyperplastic human adrenal cortex studied in vivo and in vitro.
    Kolanowski J; Crabbé J
    Ann Endocrinol (Paris); 1979; 40(5):517-8. PubMed ID: 229764
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenocortical tumour, hypoglycaemia and excessive secretion of compound S.
    WILLIAMS R
    Proc R Soc Med; 1960 Oct; 53(10):864-6. PubMed ID: 13785491
    [No Abstract]   [Full Text] [Related]  

  • 18. SWEATING studies in a case of psoriatic erythroderma under 17-hydroxycorticosterone (compound F) therapy.
    AMA Arch Derm Syphilol; 1953 Dec; 68(6):742-3. PubMed ID: 13103819
    [No Abstract]   [Full Text] [Related]  

  • 19. The local effect of 17 hydroxycorticosterone-21-acetate (compound F) on the diagnostic patch test reaction.
    GOLDMAN L; PRESTON R; ROCKWELL E
    J Invest Dermatol; 1952 Feb; 18(2):89-90. PubMed ID: 14908183
    [No Abstract]   [Full Text] [Related]  

  • 20. THE FATE OF 1,2-3H CORTEXOLONE IN MAN.
    DEHERTOGH R; HOET JJ; MATERAZZI F; EKKA E
    Acta Endocrinol (Copenh); 1964 Sep; 47():165-76. PubMed ID: 14205291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.